Please assess the completion status of the following clinical trial:

Trial Title: Addressing Racial/Ethnic Tobacco Health Disparities Via Group Intervention

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Self-identify as African American/Black, Hispanic (any race), or White non-Hispanic~* Smoke at least 5 cigarettes/day or carbon monoxide (CO) reading of at least 8 ppm~* be over age 18~* speak/read English and/or Spanish~Exclusion Criteria:~* Contraindications for transdermal nicotine patch therapy (TNP)~* Cognitive or mental health impairment that inhibits group treatment~* Currently being treated for smoking cessation, alcoholism, or illicit drug use~* Unable to attend sessions~* Indications that participant is not appropriate for the study (e.g., aggressive, intoxicated, disruptive, visibly ill)~* Does not self-identify as African American, Hispanic, or White (non-Hispanic)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Group Cognitive Behavioral Therapy (Type: EXPERIMENTAL): Participants may receive 8 group cognitive behavioral therapy (CBT) sessions and eight weeks of transdermal nicotine patches (TNP) \[21mg (4 weeks), 14mg (2 weeks), and 7mg (2 weeks)\].
- General Health Education (Type: ACTIVE_COMPARATOR): Participants may receive group general health education (GHE) sessions and eight weeks of transdermal nicotine patches (TNP) \[21mg (4 weeks), 14mg (2 weeks), and 7mg (2 weeks)\].

Based on this trial design, predict the completion outcome and termination type (if applicable).